Vanda Pharmaceuticals | VNDA - Dividend Yield


Vanda Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Anika Therapeutics 0 0 Mar/2025
AstraZeneca USD 1.74 0.4 Dec/2025
Bristol-Myers Squibb 0.22 0.04 Dec/2025
Eli Lilly 0.58 0.16 Dec/2025
Enanta Pharmaceuticals 0 0 Mar/2025
Esperion Therapeutics 0 0 Mar/2025
Heron Therapeutics 0 0 Mar/2025
J&J 2.5 0.32 Dec/2025
Lexicon Pharmaceuticals 0 0 Mar/2025
Merck 3.12 0.74 Dec/2025
Minerva Neurosciences 0 0 Mar/2025
Novartis 3.12 0.26 Sep/2025
Pfizer 6.91 0.33 Dec/2025
Puma Biotechnology 0 0 Mar/2025
Sangamo BioSciences 0 0 Mar/2025
Sanofi 4.74 0.25 Dec/2025
Takeda 4.08 0.46 Dec/2025
Vanda Pharmaceuticals 0 0 Mar/2025